Press release
Overview of Global Anti-inflammatory Therapeutics Market Professional Survey Report 2017 - AbbVie, Pfizer, Merck & Co., AstraZeneca etc.
ResearchMoz added Latest Research Report titled " Global Anti-inflammatory Therapeutics Market Professional Survey Report 2017 " to it's Large Report database.This report studies Anti-inflammatory Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
AbbVie Inc.
Pfizer Inc.
Merck & Co., Inc.
Johnson & Johnson
GlaxoSmithKline plc
AstraZeneca PLC
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1255530
Amgen Inc
Novartis AG
F. Hoffmann-La Roche AG
Eli Lily and Company
By types, the market can be split into
Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Corticosteroids
Biologics
By Application, the market can be split into
Arthritis
Psoriasis
Respiratory Disease
Browse more details @ http://www.researchmoz.us/global-anti-inflammatory-therapeutics-market-professional-survey-report-2017-report.html
Table of Contents
Global Anti-inflammatory Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Anti-inflammatory Therapeutics
1.1 Definition and Specifications of Anti-inflammatory Therapeutics
1.1.1 Definition of Anti-inflammatory Therapeutics
1.1.2 Specifications of Anti-inflammatory Therapeutics
1.2 Classification of Anti-inflammatory Therapeutics
1.2.1 Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
1.2.2 Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
1.2.3 Corticosteroids
1.2.4 Biologics
1.3 Applications of Anti-inflammatory Therapeutics
1.3.1 Arthritis
1.3.2 Psoriasis
1.3.3 Respiratory Disease
1.3.4 Multiple Sclerosis
1.3.5 Inflammatory Bowel Disease
1.3.6 Other Inflammatory Disease
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Overview of Global Anti-inflammatory Therapeutics Market Professional Survey Report 2017 - AbbVie, Pfizer, Merck & Co., AstraZeneca etc. here
News-ID: 645173 • Views: …
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…